Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estetrol for hair growth in postmenopausal women with female pattern hair loss
2024-517890-26-00Phase 2Completed
- Sponsor
- Estetra SRL
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Female Pattern Hair Loss (FPHL) comparing Estetrol monohydrate with Placebo (2 arms). Primary endpoints: Change from baseline in total anagen hair count at Week 22, Change from baseline in total anagen hair width at Week 22 and 5 more. Started Oct 2024; status: completed.
02
Drugs
estetrol
03
Conditions
Female Pattern Hair Loss (FPHL)
Beyond the preview
Go deeper on 2024-517890-26-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517890-26-00.